|
| 37527526 | Cotargeting Phosphoinositide 3-Kinase and Focal Adhesion Kinase Pathways Inhibits Proliferation of NF2 Schwannoma Cells. | | 2023 |
| 35934994 | Lack of complete response pretransplant is not associated with inferior overall survival for stage 4a metastatic retinoblastoma. | Pediatric Blood and Cancer | 2023 |
| 35604410 | Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatrics. | Neuro Oncol | 2023 |
| 37476329 | Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing. | Neurooncol Adv | 2023 |
| 37346983 | Leptomeningeal disease in histone-mutant gliomas. | | 2023 |
| 37158537 | Slipped capital femoral epiphyses: A major on-target adverse event associated with FGFR tyrosine kinase inhibitors in pediatric patients. | | 2023 |
| 37399073 | Recurrent TRAK1::RAF1 Fusions in pediatric low-grade gliomas. | Brain Pathol | 2023 |
| 37078878 | Cerebrospinal fluid: The new frontier for methylome-based diagnostic classification of brain tumors. | | 2023 |
| 36950217 | Phase II study of everolimus for recurrent or progressive pediatric ependymoma. | Neurooncol Adv | 2023 |
| 36881254 | Treatment of Pediatric Low-Grade Gliomas. | Curr Neurol Neurosci Rep | 2023 |
| 37010875 | Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma. | Neuro Oncol | 2023 |
| 37379234 | Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome. | Neuro Oncol | 2023 |
| 36853490 | Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma. | J Neurooncol | 2023 |
| 34882185 | Carboplatin During Craniospinal Radiotherapy for Children With Group 3 Medulloblastoma-A New Standard of Care? | JAMA Oncology | 2022 |
| 35397478 | Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma. | Neuro Oncol | 2022 |
| 35585047 | Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers. | Nat Commun | 2022 |
| 35986430 | YAP1-MAML2 fusion in a pediatric NF2-wildtype intraparenchymal brainstem schwannoma. | Acta Neuropathol Commun | 2022 |
| 36380863 | Tapping into the genome: the role of CSF ctDNA liquid biopsy in glioma. | Neuro-Oncology Advances | 2022 |
| 36509077 | Current Role and Future Potential of CSF ctDNA for the Diagnosis and Clinical Management of Pediatric Central Nervous System Tumors. | | 2022 |
| 35171291 | Chemotherapy plus focal radiation therapy for localized intracranial germinoma: How little is enough? | Neuro-Oncology | 2022 |
| 35148412 | Next-generation sequencing of cerebrospinal fluid for clinical molecular diagnostics in pediatric, adolescent and young adult brain tumor patients. | Neuro Oncol | 2022 |
| 34417833 | PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum. | Acta Neuropathol | 2021 |
| 33705546 | Pediatric spinal cord gliomas-low grade but high risk for recurrence: should we treat them differently from intracranial low-grade gliomas? | Neuro-Oncology | 2021 |
| 34277017 | Genetic syndromes predisposing to pediatric brain tumors. | Neuro-Oncology Practice | 2021 |
| 34224367 | Phase 0 Clinical Trial of Everolimus in Patients with Vestibular Schwannoma or Meningioma. | Mol Cancer Ther | 2021 |
| 33838625 | Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas. | N Engl J Med | 2021 |
| 33781965 | Clinical Experience of Cerebrospinal Fluid-Based Liquid Biopsy Demonstrates Superiority of Cell-Free DNA over Cell Pellet Genomic DNA for Molecular Profiling. | J Mol Diagn | 2021 |
| 34250399 | Debio1347, an Oral FGFR Inhibitor: Results From a Single-Center Study in Pediatric Patients With Recurrent or Refractory FGFR-Altered Gliomas. | JCO Precision Oncology | 2021 |
| 34308366 | Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors. | Nat Cancer | 2021 |
| 33547247 | Correction: Combined Inhibition of NEDD8-activating Enzyme and mTOR Suppresses NF2 Loss-driven Tumorigenesis. | Mol Cancer Ther | 2021 |
| 33547201 | A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium Study. | Clin Cancer Res | 2021 |
| 33140540 | A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma. | Pediatr Blood Cancer | 2021 |
| 33226472 | Malignant transformation of a polymorphous low grade neuroepithelial tumor of the young (PLNTY). | Acta Neuropathol | 2021 |
| 34495383 | Molecular profiling of pediatric meningiomas shows tumor characteristics distinct from adult meningiomas. | Acta Neuropathol | 2021 |
| 31375903 | Subgroup-specific outcomes of children with malignant childhood brain tumors treated with an irradiation-sparing protocol. | Child's Nervous System | 2020 |
| 31786090 | Time to advance methylation profiling to the forefront of primary diagnostics for childhood brain tumours. | | 2020 |
| 32238360 | Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes. | Cancer Discov | 2020 |
| 32289278 | Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas. | Cancer Cell | 2020 |
| 31768671 | Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations. | Acta Neuropathol | 2020 |
| 33040274 | A phase I trial of lenalidomide and radiotherapy in children with diffuse intrinsic pontine gliomas or high-grade gliomas. | J Neurooncol | 2020 |
| 32923898 | Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF Inhibition. | JCO Precis Oncol | 2020 |
| 33014398 | Letter to the Editor regarding clinical debate concerning treatment of pediatric LGG by Cooney et al. | Neurooncol Pract | 2020 |
| 30852609 | The new kid on the block: suicide gene therapy to modulate cancer immunosurveillance for children with high-risk malignant brain tumors. | Neuro-Oncology | 2019 |
| 31802000 | The molecular landscape of ETMR at diagnosis and relapse. | Nature | 2019 |
| 31645348 | Histone H3K36I mutation in a metastatic histiocytic tumor of the skull and response to sarcoma chemotherapy. | Cold Spring Harb Mol Case Stud | 2019 |
| 31626572 | Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma. | J Clin Oncol | 2019 |
| 31180122 | Sustained imaging response and hearing preservation with low-dose bevacizumab in sporadic vestibular schwannoma. | Neuro-Oncology | 2019 |
| 31456142 | Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201. | J Neurooncol | 2019 |
| 31171721 | Peroxynitrite supports a metabolic reprogramming in merlin-deficient Schwann cells and promotes cell survival. | Journal of Biological Chemistry | 2019 |
| 29539639 | DNA methylation-based classification of central nervous system tumours. | Nature | 2018 |